Providers consider current health status, medication safety, digestive history, family and personal medical history, prior weight loss attempts, and treatment goals before recommending Tirzepatide
Future directions should prioritize RCTs targeting early-stage glaucoma, with primary endpoints encompassing both structural (e.g., OCT-based RGC metrics) and functional (e.g., visual field preservation) outcomes, to validate the potential of GLP-1RAs as a true disease-modifying strategy in glaucoma management
healthy males and females present cardiometabolic protection against the detrimental effects of a 7-day high-fat high-calorie diet
These starter doses are usually insufficient to produce noticeable appetite reduction, which can confuse patients who expect immediate results. The first 4-8 weeks on GLP-1 medication represents an adjustment period where your experience might differ significantly from long-term expectations